{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:52:21Z","timestamp":1648961541036},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T00:00:00Z","timestamp":1315872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10096-011-1394-8","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T11:55:37Z","timestamp":1315828537000},"page":"975-980","source":"Crossref","is-referenced-by-count":0,"title":["Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae"],"prefix":"10.1007","volume":"31","author":[{"given":"M.","family":"Parta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,13]]},"reference":[{"key":"1394_CR1","unstructured":"CLSI (2010) Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI document M100-20"},{"key":"1394_CR2","unstructured":"CLSI (2010) Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI document M100-20u"},{"issue":"1","key":"1394_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/JCM.44.1.241-243.2006","volume":"44","author":"MJ Schwaber","year":"2006","unstructured":"Schwaber MJ, Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwartz D, Carmeli Y (2006) Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. J Clin Microbiol 44(1):241\u2013243","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1394_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/JCM.00219-10","volume":"48","author":"KS Thomson","year":"2010","unstructured":"Thomson KS (2010) Extended-spectrum-beta-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol 48(4):1019\u20131025","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1394_CR5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/JCM.38.2.570-574.2000","volume":"38","author":"CC Sanders","year":"2000","unstructured":"Sanders CC, Peyret M, Moland ES, Shubert C, Thomson KS, Boeufgras JM, Sanders WE Jr (2000) Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol 38(2):570\u2013574","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1394_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/AAC.01041-09","volume":"54","author":"PD Mauldin","year":"2010","unstructured":"Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA (2010) Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother 54(1):109\u2013115","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1394_CR7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-117-3-257","volume":"117","author":"SW Dooley","year":"1992","unstructured":"Dooley SW, Jarvis WR, Martone WJ, Snider DE Jr (1992) Multidrug-resistant tuberculosis. Ann Intern Med 117(3):257\u2013259","journal-title":"Ann Intern Med"},{"issue":"12","key":"1394_CR8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/657313","volume":"51","author":"TM File Jr","year":"2010","unstructured":"File TM Jr, Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley I, Thye D (2010) Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 51(12):1395\u20131405","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1394_CR9","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01808-09","volume":"54","author":"DJ Hoban","year":"2010","unstructured":"Hoban DJ, Bouchillon SK, Hawser SP, Badal RE, Labombardi VJ, DiPersio J (2010) Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007\u20132008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 54(7):3031\u20133034","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1394_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.00106-08","volume":"53","author":"BS Chin","year":"2009","unstructured":"Chin BS, Seo WY, Paterson DL, Potoski BA, Peleg AY (2009) Cefepime MIC breakpoint resettlement in gram-negative bacteria. Antimicrob Agents Chemother 53(1):337\u2013338","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1394_CR11","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1128\/JCM.43.9.4891-4894.2005","volume":"43","author":"W Song","year":"2005","unstructured":"Song W, Moland ES, Hanson ND, Lewis JS, Jorgensen JH, Thomson KS (2005) Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia. J Clin Microbiol 43(9):4891\u20134894","journal-title":"J Clin Microbiol"},{"issue":"6","key":"1394_CR12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/520991","volume":"45","author":"GL Drusano","year":"2007","unstructured":"Drusano GL, Ambrose PG, Bhavnani SM, Bertino JS, Nafziger AN, Louie A (2007) Back to the future: using aminoglycosides again and how to dose them optimally. Clin Infect Dis 45(6):753\u2013760","journal-title":"Clin Infect Dis"},{"key":"1394_CR13","doi-asserted-by":"crossref","unstructured":"Mataseje LF, Boyd DA, Willey BM, Prayitno N, Kreiswirth N, Gelosia A, Poutanen SM, Low DE, Jenkins SG, Katz K, Mulvey MR (2011) Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring blaKPC from New York City and Toronto. J Antimicrob Chemother 66(6):1273\u20131277","DOI":"10.1093\/jac\/dkr092"},{"issue":"8","key":"1394_CR14","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/JCM.00508-09","volume":"47","author":"PC Kohner","year":"2009","unstructured":"Kohner PC, Robberts FJ, Cockerill FR 3rd, Patel R (2009) Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species. J Clin Microbiol 47(8):2419\u20132425","journal-title":"J Clin Microbiol"},{"issue":"8554","key":"1394_CR15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(87)90891-9","volume":"2","author":"C Brun-Buisson","year":"1987","unstructured":"Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J (1987) Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 2(8554):302\u2013306","journal-title":"Lancet"},{"issue":"9","key":"1394_CR16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/AAC.33.9.1451","volume":"33","author":"JP Quinn","year":"1989","unstructured":"Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K (1989) Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 33(9):1451\u20131456","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1394_CR17","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.34.11.2193","volume":"34","author":"LB Rice","year":"1990","unstructured":"Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC Jr, Jacoby GA (1990) Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 34(11):2193\u20132199","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1394_CR18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.34.6.1290","volume":"34","author":"CE Smith","year":"1990","unstructured":"Smith CE, Tillman BS, Howell AW, Longfield RN, Jorgensen JH (1990) Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother 34(6):1290\u20131293","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1394-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1394-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1394-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T17:17:16Z","timestamp":1592932636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1394-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,13]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1394-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,13]]}}}